GlassScriptPhysician profile
Joseph J Maselli
NPI 1548256720
$4,586.53
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,987 · 2020: $1,293 · 2021: $1,072 · 2022: $236.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,420.41 | 2019-2022 | |
| Avion Pharmaceuticals | $532.72 | 2019-2022 | |
| Lupin INC. | $512.90 | 2019-2021 | |
| Therapeuticsmd, INC. | $443.21 | 2019-2022 | |
| Exeltis, USA INC. | $421.11 | 2019-2022 | |
| Allergan, INC. | $181.31 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $137.24 | 2019-2020 | |
| Organon LLC | $122.42 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $122.07 | 2021-2022 | |
| Duchesnay USA Incorporated | $111.22 | 2019 | |
| Vertical Pharmaceuticals, LLC | $104.60 | 2019 | |
| Pfizer INC. | $86.48 | 2019-2021 | |
| Agile Therapeutics, INC. | $86.25 | 2021 | |
| Myovant Sciences INC. | $77.46 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.75 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $63.63 | 2020-2021 | |
| Hologic Sales and Service, LLC | $38.26 | 2019-2021 | |
| Amgen INC. | $19.47 | 2020 | |
| Coopersurgical, INC. | $16.77 | 2019 | |
| Millicent US INC | $14.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Maselli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.